Construction of the new facility will begin in April, with the building to cover an area of 1,500 square metres. The facility will provide end-to-end handling in a temperature-controlled environment for 2-8°C pharma products, accommodating acceptance, offload, pre-storage, build-up and storage.
Accessible through four dedicated cargo doors, the facility will accept loose shipments and pre-built units, offering a storage area large enough for 300 EUR pallets and 30 PMC pallets. WFS expects the construction process to be completed in time for the new building to undergo IATA CEIV Pharma pre-assessment in July.
WFS is also upgrading the temperature control areas in its current facility in Copenhagen to handle growing volumes of pharma products requiring a 15-25°C temperature range. This will be the company’s second investment in pharma facilities at the airport in under two years. WFS opened the first stage of its pharma infrastructure in Copenhagen at the end of 2017, since which time it has seen volumes of pharma shipments grow by 90%.
John Batten, EVP Cargo for Europe, Middle East, Africa & Asia (EMEAA), said: “This new investment in Copenhagen reflects our continued commitment to support airport cargo communities with growing pharma volumes. We already have IATA CEIV certified locations in Amsterdam, Barcelona, Brussels, Frankfurt, Madrid and Miami, and we have further investments planned to upgrade our pharma capabilities in other key WFS stations in the year ahead.”
